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http://dx.doi.org/10.1016/j.jmii.2013Background/Purpose: Human immunodeficiency virus (HIV) and syphilis coinfection is a com-
mon phenomenon. A percentage of neurosyphilis cases is asymptomatic in HIV-infected pa-
tients. The diagnosis of neurosyphilis is more difficult because of the alteration of
cerebrospinal fluid (CSF) presentation by the HIV itself. The CSF levels of the degradation prod-
ucts of nitric oxide (NO; e.g., nitrate and nitrite) are reportedly elevated in animals and pa-
tients with bacterial meningitis. We hypothesized that an elevated CSF nitrite concentration
may be present in patients coinfected with HIV and neurosyphilis.
Methods: This cohort study was conducted from January 2007 to June 2008. Forty patients
were enrolled and included seven patients in the control group and 33 HIV-infected patients
with or without syphilis. Nitrite levels in the serum and the CSF were measured by using the
Griess assay.
Results: The CSF nitrite levels were significantly higher in HIV-infected patients with neurosy-
philis, compared to the control group or patients with HIV infection only or patients with HIVfectious Diseases, Department of Medicine, Kaohsiung Veterans General Hospital, 386 Ta-Chung First
.com.tw (Y.-S. Chen).
uted equally to this study.
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Cerebrospinal fluid nitrites in neurosyphilis 513and syphilis coinfection (pZ 0.026). The CSF nitrite levels were correlated with the CSF white
blood cell counts (Spearman correlation test, r2Z 0.324; p < 0.001). There was no significant
difference between different groups in serum nitrite levels.
Conclusion: Marked elevation of CSF nitrite level was observed in HIV-infected patients with
neurosyphilis.
Copyright ª 2013, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Human immunodeficiency virus (HIV) and syphilis coinfec-
tion is a common phenomenon among men having sex with
men (MSM).1e3 Each disease alters the clinical presentation
of the other. Syphilis may have a negative impact on HIV
transmission and on the immune status. It can decrease the
CD4 T cell count and increase the viral load in HIV-infected
patients.4e6 Because of the effect of HIV on the immune
system, HIV infection may change the presentation, diag-
nosis, and natural course of syphilis and accelerate its
progression to neurosyphilis.7
The prevalence of asymptomatic neurosyphilis in HIV-
infected patients is high7,8; however, diagnosis is difficult
and the timing of lumbar puncture remains controversial.
The prevalence of neurosyphilis is 0.4% in HIV-infected
patients and 23.5% in HIV-infected patients with un-
treated syphilis.9 In one study of 117 HIV-infected patients
with a diagnosis of neurosyphilis, one-third of the patients
were asymptomatic.7 In another study in Taiwan, which
enrolled 121 patients with HIV and syphilis coinfection, 14
of the patients had neurosyphilis and two of the 14 patients
were asymptomatic.8 The diagnosis of neurosyphilis in HIV-
infected people may be more challenging because CSF
pleocytosis and protein elevation can occur with HIV
infection alone.10,11 Two recent studies report a significant
association between serum rapid plasma reagin (RPR) titers
of 1:32 and neurosyphilis.12,13 The U.S. Centers for Dis-
ease Control and Prevention recommend that CSF exami-
nation should be performed for HIV-infected individuals
who are diagnosed with syphilis at the late latent stage or
have syphilis with unknown duration, who have neurologic
signs or symptoms, or who have suspected treatment fail-
ure.14 For syphilis patients who have HIV coinfection, a CSF
leukocyte count greater than 20 cells/mL is consistent with
neurosyphilis.12
For a better diagnosis of neurosyphilis in HIV-infected
patients, some studies suggest using the CSF Treponema
pallidum hemagglutination assay (TPHA),15 the CSF fluo-
rescent treponemal antibody (FTA),16 the percentage of
CSF B cells,16 CSF C-X-C motif chemokine 13 (CXCL13),17
and CSF matrix metalloproteinases-9 (MMP-9).18 T. pal-
lidum DNA polymerase chain reaction (PCR) analysis of the
CSF did not provide more information than conventional
CSF analysis.19 Nitric oxide (NO), which is generated by
phagocytes, plays a role in inflammation and immune re-
sponses, and may consequently result in neuronal toxicity
and dysfunction. Studies have shown that increased NO
metabolites are present in patients with meningitis.20e22
The hypothesis of our study is that neurosyphilis may be
correlated with the elevation of NO metabolites in the CSF.For this purpose, the serum and CSF levels of nitrites were
studied in HIV-infected patients with syphilis or neuro-
syphilis and in control individuals.
Methods
Participants
Patients were selected from a cohort of patients and fol-
lowed from January 2007 to June 2008. Syphilis was defined
as a reactive serum test [i.e., venereal disease research
laboratory (VDRL) test or RPR test] that was confirmed by a
treponemal serological test (i.e., TPHA). Lumbar puncture
was performed if the patient had neurological or ophthal-
mological symptoms or signs, and a lumbar puncture was
performed in HIV-infected patients with late latent syphilis
or syphilis of unknown duration.14 Neurosyphilis was
defined as a CSF white blood cell (WBC) count of at least
20 cells/mL or by a reactive CSF VDRL test. Patients were
defined as having HIV infection if the enzyme-linked
immunosorbent assay (ELISA) and Western blot procedure
were both positive.
Among these patients, seven patients were negative for
both HIV and syphilis infection and were defined as the
control group. To exclude tumor, subarachnoid hemor-
rhage, inflammatory disease, or meningitis, the patients
received a lumbar puncture because of the clinical pre-
sentation of fever with headache (n Z 3) or altered con-
sciousness (n Z 4). Six patients were HIV-positive without
syphilis. They received lumbar puncture because of head-
ache (nZ 2), altered consciousness (nZ 1), fever (nZ 1),
limb weakness (n Z 1), and gait disturbance (n Z 1).
Twenty seven patients had HIV and syphilis coinfection, and
eight of these were diagnosed as having neurosyphilis.
Plasma HIV-RNA copy number, peripheral blood CD4 þ T
lymphocyte count, and clinical manifestations were recor-
ded. Serum samples were also tested in another 11 pa-
tients, who received anonymous screening for sexually
transmitted diseases (STDs) and tested as HIV-1enegative
but syphilis positive. The study protocol, including an
informed written consent form, was approved by the
Commission on Medical Ethics of the Kaohsiung Veterans
General Hospital (Kaohsiung, Taiwan).
Nitrite concentration measurement in the CSF and
in serum
The CSF and serum samples were centrifuged and the su-
pernatants were frozen at 80C until assayed. The nitrite
levels in CSF and serum were determined by a colorimetric
514 Y.-J. Cheng et al.method,23 after enzymatic reduction of nitrate to nitrite by
using nitrate reductase (1 U/mL) from Aspergillus (Boeh-
ringer, Mannheim, Germany). The lower limit of detection
was 0.2 mmol/L.
Statistical analysis
All continuous variables were expressed as the median and
the interquartile range (IQR). Concentrations of nitrite in
the CSF and in the serum of the patients and the controls
were compared by the Mann-Whitney U test. The concen-
tration of nitrite in the CSF and serum in HIV-infected pa-
tients with neurosyphilis, HIV-infected patients with
syphilis, HIV-infected patients, and the controls were
compared by the Kruskal-Wallis H test and the Dunn’s
multiple comparison test. Correlations between CSF nitrite
level and the other variables were calculated by using the
Spearman correlation test. A p value < 0.05 was considered
statistically significant.Results
Participants
Forty patients were enrolled and were followed from
January 2007 to June 2008. Table 1 summarizes the clinical
characteristics of the 33 patients with HIV infection andTable 1 Clinical characteristics of the HIV-infected patients an
Clinical characteristics C
Age (y), median age (IQR) 4
Sex
Male 6
Risk factors
MSM N
Heterosexual N
Indications for lumbar puncture
Fever 3
Headache 0
Neurological symptomsa 0
Consciousness change 4
Visual acuity change 0
Serum RPR 1:32 0
Late latent syphilis or syphilis of unknown duration 0
CD4 count (cells/uL), median count (IQR) N
HIV RNA (copies/mL in log), median (IQR) N
Serum RPR titer
1:32 N
<1:32 N
Neurosyphilis
Reactive CSF VDRL N
CSF WBC 20 cells/uLb N
a Neurological symptoms include dizziness, ataxia, limb weakness,
b One patient with CSF pleocytosis was diagnosed as having syphilit
Data are presented as n (%).
CSF Z cerebrospinal fluid; HIV Z human immunodeficiency virus; IQ
NA Z not available; RPR Z rapid plasma reagin; VDRL Z Venereal Dthe seven controls. The CSF white blood cell counts of the
control group ranged from 0 cells/mL to 3 cells/mL. Of the
eight patients with neurosyphilis, one patient was asymp-
tomatic and received lumbar puncture because of a high
serum RPR level (1:64). There was no difference in the CD4
cell count or HIV viral load between HIV-infected patients
with and without syphilis (p Z 0.097 and p Z 0.792,
respectively) or between HIV-infected patients with and
without neurosyphilis (p Z 0.571 and 0.796, respectively).
In patients with HIV and syphilis coinfection, the titer of
serum RPR was significantly higher in the patients with
neurosyphilis (p Z 0.015).
CSF white blood cell count and nitrite levels
There was no significant difference in the CSF white blood
cell counts between patients with and without HIV infec-
tion (p Z 0.250; Table 2). This may have resulted from
the small patient group. The CSF nitrite level was signifi-
cantly higher in HIV and syphilis coinfected patients
with neurosyphilis than in patients without neurosyphilis
(p Z 0.047). The HIV-infected patients with neurosyphilis
had a higher CSF nitrite level than other patient groups
(pZ 0.015, compared to all patients without neurosyphilis;
and p Z 0.03, compared to HIV-infected patients without
neurosyphilis; Fig. 1). The CSF nitrite level was also higher
in patients with HIV or syphilis than in patients without
these diseases (p Z 0.043 and 0.048, respectively).d the control group
ontrol group (n Z 7) HIV-infected patients
(n Z 33)
6 (34e86) 33 (29e43)
(86) 33 (100)
A 27 (82)
A 6 (18)
(43) 1 (3)
5 (15)
5 (15)
(57) 3 (9)
2 (6)
16 (49)
1 (3)
A 311 (117.5e456)
A 3.83 (0e4.33)
A 25 (76)
A 8 (24)
A 5 (15)
A 3 (9)
and twitching.
ic panuveitis.
R Z interquartile range; MSM Z men who have sex with men;
isease Research Laboratory; WBC Z white blood cell count.
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Figure 1. The CSF nitrite level is significantly higher in pa-
tients with HIV and neurosyphilis than in the other patient
groups. CSF Z cerebrospinal fluid; HIV Z human immunode-
ficiency virus. *Indicates a significant difference, p < 0.05.
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There was no significant difference in the serum nitrite
levels between the control group, patients with HIV infec-
tion only, patients with HIV infection and syphilis, and pa-
tients with HIV infection and neurosyphilis (p Z 0.735;
Fig. 2). In patients with syphilis only (i.e., patients who
received an anonymous screen for STDs), the serum nitrites
level was significantly lower than in the other patient
groups (p Z 0.004).
Correlation between CSF nitrites and laboratory
parameters
There was an association between the CSF nitrite level and
the CSF white blood cell count (r2 Z 0.324, p < 0.001).
However, elevated CSF nitrite levels were observed in HIV-
infected patients who had neurosyphilis without CSF pleo-
cytosis. There were six neurosyphilis patients without CSF
pleocytosis (i.e., CSF white blood cell count less than
20 cells/mL), but the CSF nitrite level was remained higher
in this patient group in comparison to HIV and syphilis
coinfected patients (p Z 0.03). There was also a weak but
insignificant correlation between the CSF nitrite level and
the HIV plasma viral load (r2 Z 0.069, p Z 0.166).
Discussion
In our study, the CSF nitrite levels were significantly higher
in HIV-infected patients with neurosyphilis than in other
patient groups. There was also a correlation between the
CSF nitrite levels and the WBC count. The CSF nitrite levels
remained significantly elevated, even after we excluded
two neurosyphilis patients with CSF pleocytosis. It is clini-
cally difficult to diagnose neurosyphilis in HIV-infected pa-
tients with a single marker. Despite the use of traditional
CSF markers such as VDRL, WBC count, and protein level,
our study showed that an elevated CSF nitrite level is also
present in patients with neurosyphilis.
Figure 2. No significant difference exists in the serum nitrite
levels of the patients in the control group, in patients with HIV,
in patients with HIV and syphilis, and in patients with HIV and
neurosyphilis. HIV Z human immunodeficiency virus.
516 Y.-J. Cheng et al.The cellular site of CSF nitrite production in our patients
with HIV and neurosyphilis is unknown. Nitrites can be
generated by a variety of cell types such as neutrophils,
microglia, endothelial cells, astrocytes, neurons, vascular
smooth muscle cells, and bacterial cells.24 Tumor necrosis
factor alpha (TNF-a) in the CSF was also involved in the
induction of arginine-dependent NO production in the CSF
compartment of patients with bacterial meningitis.24 It is
possible that the elevated levels of CSF nitrites in our pa-
tients were because of the influx of WBCs, cytokines, and
other unidentified factors.
The clinical impact of NO in the CSF of patients with
meningitis has been discussed in detail in several studies.
One study, which enrolled 73 patients (including 26 patients
with meningitis), reported negative findings with regards to
elevated CSF nitrite levels in patients with meningitis.25
The clinical information of the patients was limited in
that study.
By contrast, more studies have shown marked elevation
of the NO level in the CSF during central nervous system
(CNS) infection with various kinds of pathogens. Infection
by HIV-1 alone may increase NO production, possibly
because of monocyte activation associated with lipopoly-
saccharide or TNF-a, or through interactions with astroglial
cells.26 The dysregulation or overexpression of NO conse-
quently contributes to neurologic damage associated with
various pathologies.27 However, another study shows no
significant increase in the CSF levels of NO metabolites in
HIV-infected patients, but the increase in the metabolites
was significant in patients with bacterial meningitis or viral
meningitis.20 Another study also reports a significantly
greater NO concentration in the CSF in patients with bac-
terial meningitis than in patients with viral meningitis.22
In an animal model, the expression of inducible NO
synthase (NOS) in the neurons and astrocytes was corre-
lated with the detection of bovine herpes virus 5.28 In one
study, blood and CSF samples were collected from 61 pa-
tients with meningitis and 64 healthy individuals; the re-
sults showed markedly elevated endothelial NOS mRNA in
the patient group.29 Another study reports a significantlypositive correlation between the nitrite level and gran-
ulocyte counts in the CSF of 100 pediatric patients with
viral and bacterial meningitis.21
In our study, an elevation in the CSF nitrite level was
present in patients with HIV and syphilis infection, but the
difference was most significant in patients with neuro-
syphilis, despite underlying HIV infection. There were no
significant differences between patients with and without
neurosyphilis in the serum nitrite levels. Why CSF nitrite
levels were higher in patients with neurosyphilis cannot be
explained, although serum NO metabolites may penetrate
into the CSF during CNS inflammation. Our study showed a
low correlation between the CSF nitrite levels and CSF
white blood cell counts. The increase in NO metabolites
may just be a byproduct of CSF pleocytosis; however, an
increased CSF nitrite level was present in neurosyphilis
patients without CSF pleocytosis. The results of this study
imply that increased NO metabolites in the CSF indicates a
local immune response to CNS infection and that neuro-
syphilis may contribute to this phenomenon to a greater
degree than HIV infection in coinfected patients.
There were a number of limitations in this study. Our
sample size and control group were small. Patients with
diseases that cause CSF pleocytosis such as bacterial men-
ingitis and tuberculosis meningitis were not included. We
did not collect the CSF data in syphilis patients who did not
have HIV infection; however, it is unfeasible and unethical
to perform lumbar puncture in such patients without CNS
symptoms. Furthermore, we did not collect CSF data in the
neurosyphilis patients after they received antibiotic ther-
apy; as a result, CSF nitrite response to the therapy remains
unknown.
In conclusion, the CSF nitrite levels were significantly
higher in HIV-infected patients with neurosyphilis than in
patients without neurosyphilis. More trials are needed to
explain further the pathophysiology and clinical applica-
tions of this phenomenon.Conflicts of interest
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